The Group's principal activities are divided into three segments: interventional cardiology, licensing revenue and critical care. The interventional cardiology segment supplies the Group's proprietary coronary bare-metal stent, accompanying stent delivery balloon catheter system, angioplasty balloons and catheters. The licensing revenue segment relates to milestone payments associated with the licensing of the Group's proprietary drug-eluting stent technology and intellectual property. The critical care segment supplies catheter systems and related accessories used during heart surgery and intensive care treatment and monitoring.
Alacra Alerts:
Receive alerts on the latest reports on Biosensors International Group Ltd
Subscribe to Alacra Alerts via RSS and never miss the latest research on your favorite companies. Just click the images above to add the feed directly to your favorite newsreader.
